CRPPA and tuberculosis: Thereby in this study, we selected M6 as a probe molecule to identify potential drug targets for anti-TB treatment by molecular docking, and then found that IspD is one of M6 targets in M. smegmatis via multiple approaches including enzyme kinetics and CRISPRi.